Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic Albuterol

NCT00325767 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Mucociliary Clearance

Interventions

DRUG: nebulized albuterol (2.5 mg/3ml/dose)
DRUG: nebulized levalbuterol (1.25 mg/3ml/dose)
DRUG: nebulized placebo (3ml/dose)

Sponsor

Johns Hopkins University

Collaborators

[object Object]